Truvada was approved by the Food and Drug Administration in 2012 as the country's first HIV prevention strategy. The drug referred to as 'PrEP,' stands for pre-exposure prophylaxis. According to the Centers for Disease Control, the drug when taken consistently can reduce the contraction of HIV by up to 92%.
Path to Full Story on KERO Channel 23 ABC News